Award Sub-Category: Therapeutic Impact

The Seraph 100 binds with SARS-CoV-2. Clinicians have reported a reduction in inflammatory markers such as IL-6, d-dimer, and ferritin, hemodynamic stabilization, reduction of vasopressors and fractionally inspired oxygen, avoidance or reduction of mechanical ventilation, and a 4x increase of survival rate of critically ill patients.

Hummingbird™ EQ with Air Vaccine™ deactivates Covid-19 and other viruses with 99.5% efficacy on the first pass of airflow from the HVAC system. This integrated hardware, software and cloud solution are scalable to any size HVAC system and include a unique, scannable QR code to instantly report the indoor air quality of a building prior to entry.

Certara’s Simcyp COVID-19 Vaccine Model employs biosimulation and computer-generated, virtual populations to facilitate global vaccine decision-making. It addresses important COVID-19 vaccine questions such as optimal dose and timing, whether there are differences in immune response with age and ethnicity and expected duration of antibody response.